Markus Grompe is joining our Scientific Advisory Board
We’re excited to announce that Markus Grompe is joining our Scientific Advisory Board to support our Metabolism program.
Markus’ laboratory is responsible for much of our collective knowledge about human hepatocyte biology. Among other notable accomplishments, they developed a system to build models of a human liver in mice with a series of clever genetic tricks. These tools allow our scientists to study the effects of partial reprogramming in real, human cells, rather than cells from other species with quite different biology. Alongside his experience in the laboratory, Markus is an experienced company builder through his work at Yecuris and Ambys Medicines.
Markus has inspired and helped advise our Metabolism program from the earliest days. We look forward to working with him for years to come.
About Markus Grompe, MD
See Markus Grompe’s profile from Oregon Health & Sciences University and Wikipedia. Paraphrased below.
Dr. Grompe is a Professor at Oregon Health and Sciences University, the director of the Oregon Stem Cell Center, and the holder of the Ray Hickey Chair and the Director of the Papé Family Pediatric Research Institute. The Grompe lab is focused on developing cell and gene therapies for genetic disorders, especially metabolic disorders of the liver. Among other accomplishments, the Grompe lab developed the first mouse models that allow for competitive repopulation of hepatocytes and further developed the first humanized liver models.
Dr. Grompe has also served as the co-founder and Chief Scientific Officer of Ambys Medicines and the founder of Yecuris.
Dr. Grompe received his M.D. in 1982 at the University of Ulm Medical School in Germany. He completed training at OHSU and Baylor College of Medicine focused on gene therapy for inherited diseases, particularly liver diseases.